Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer

被引:23
|
作者
Obeng-Gyasi, Samilia [1 ]
Li, Yaming [2 ]
Carson, William E. [1 ]
Reisenger, Sarah [3 ]
Presley, Carolyn J. [3 ]
Shields, Peter G. [3 ]
Carbone, David P. [3 ]
Ceppa, DuyKhanh P. [4 ]
Carlos, Ruth C. [5 ]
Andersen, Barbara L. [6 ]
机构
[1] Ohio State Univ, Dept Surg, Div Surg Oncol, 410 W 10th Ave,Room N924 Doan Hall, Columbus, OH 43210 USA
[2] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA
[3] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[4] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[5] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[6] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
NATIONAL SAMPLE; WOMENS HEALTH; SURVIVAL; SCORE; ADAPTATION; DISEASE; STRESS;
D O I
10.1001/jamanetworkopen.2022.21626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Adverse social determinants of health (SDHs) (eg, poverty) are associated with poor oncologic outcomes among patients with lung cancer. However, no studies have evaluated biological correlates of adverse SDHs, operationalized as allostatic load (AL), with mortality due to lung cancer. OBJECTIVE To examine the association among AL, SDHs, and mortality among patients with metastatic non-small cell lung cancer (NSCLC). DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study of an observational cohort was performed at a National Cancer Institute-designated comprehensive cancer center with data accrued from June 1, 2017, to August 31, 2019. Patients with metastatic (stage IV) NSCLC enrolled at diagnosis into a prospective observational cohort study were included in the present analysis if they had all the biomarkers to calculate an AL score (N = 143). Follow-up was completed on August 31, 2021, and data were analyzed from July 1 to September 30, 2021. EXPOSURES Social determinants of health. MAIN OUTCOMES AND MEASURES Overall mortality and AL. RESULTS A total of 143 patients met the study criteria with a median age of 63 (IQR, 55-71) years (89 men [62.2%] and 54 women [37.8%]). In terms of race and ethnicity, 1 patient (0.7%) was Asian, 7 (4.9%) were Black, 117 (81.8%) were White, 17 (11.9%) were of multiple races, and 1 (0.7%) was of other race or ethnicity. The mean (SD) AL was 2.90 (1.37). Elevated AL covaried with lower educational level (r = -0.26; P = .002), male sex (r = 0.19; P = .02), limited mobility (r = 0.19; P = .04), worsening self-care (r = 0.30; P < .001), problems engaging in usual activities (r = 0.21; P = .01), depressive symptoms (r = 0.23; P = .005), and a high number of stressful life events (r = 0.30; P < .001). Multivariable analysis found only increasing difficulty with mobility (r = 0.37 [95% CI, 0.13-0.60]; P = .002) and male sex (r = 0.63 [95% CI, 0.19-1.08]; P = .005) associated with higher AL. On adjusted analysis, elevated AL (hazard ratio, 1.43 [95% CI, 1.16-1.79]; P = .001) and low educational level (hazard ratio, 2.11 [95% CI, 1.03-4.34]; P = .04) were associated with worse overall mortality. CONCLUSIONS AND RELEVANCE The findings of this cross-sectional study suggest that higher AL was associated with adverse SDHs and worse overall mortality among patients with advanced NSCLC. These results provide a framework for replication and further studies of AL as a biological correlate for SDH and future prognostic marker.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer
    Sun, Lova
    Bleiberg, Benjamin
    Hwang, Wei-Ting
    Marmarelis, Melina E.
    Langer, Corey J.
    Singh, Aditi
    Cohen, Roger B.
    Mamtani, Ronac
    Aggarwal, Charu
    JAMA ONCOLOGY, 2023, 9 (08) : 1075 - 1082
  • [42] Overall survival of patients with non-small cell lung cancer after surgery treatment
    Loncarevic, Olivera
    Acimovic, Slobodan
    Vukovic, Jelena
    Stojisavljevic, Marko
    Maric, Nebojsa
    Loncarevic, Slobodan
    Petrovic, Marina
    Milivojevic, Ivana
    Ignjic, Gordana
    Milic, Gordana
    Mirilo, Leonida
    Rancic, Nemanja
    VOJNOSANITETSKI PREGLED, 2018, 75 (12) : 1157 - 1164
  • [43] Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
    Brouns, Anita J. W. M.
    Hendriks, Lizza E. L.
    Robbesom-van den Berge, Iris J.
    Driessen, Annemariek J. H. M.
    Roemen, Guido M. J. M.
    van Herpen, Britt L. . J.
    Dekkers, Zoe
    Heitzer, Bas
    Leunissen, Daphne J. G.
    Moonen, Laura
    Lunde, Ragnar
    Westenend, Marcel
    van Driel, Marjolein
    Speel, Ernst-Jan M.
    Dingemans, Anne-Marie C.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] THE ASSOCIATION BETWEEN METFORMIN EXPOSURE AND SURVIVAL AMONG DIABETIC PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W. B.
    VALUE IN HEALTH, 2018, 21 : S23 - S23
  • [45] The Association Between Tumor Burden and the Efficacy of Immunotherapy Among Patients With Non-small Cell Lung Cancer
    Hui, Jia-Jun
    Yan, Han-Lu
    Ding, Sheng-Jun
    Qin, Bao-Dong
    Jiao, Xiao-Dong
    Zang, Yuan-Sheng
    CANCER CONTROL, 2025, 32
  • [46] Metastatic non-small cell lung cancer: A case study
    Sherry, Victoria
    NURSE PRACTITIONER, 2016, 41 (12): : 1 - 5
  • [47] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511
  • [48] Metastatic Ureteral Involvement of Non-Small Cell Lung Cancer
    Kodama, Koichi
    Imao, Tetsuya
    Komatsu, Kazuto
    CASE REPORTS IN MEDICINE, 2011, 2011
  • [49] Afatinib for the treatment of metastatic non-small cell lung cancer
    Joshi, Monika
    Rizvi, Syed M.
    Belani, Chandra P.
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 75 - 82
  • [50] Attrition in the Treatment of Metastatic Non-Small Cell Lung Cancer
    Yang, F.
    Chen, L.
    Cheung, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 237 - 237